Progress of clinical research on neonatal platelet transfusion
Platelet transfusion is one of the critical clinical therapies of neonatal thrombocytopenia and significant preventive measures of bleeding diseases in preterm infants.The platelet transfusion rate is high in clinical practice,whereas some controversies emerge in its clinical application.Platelet transfusion decision-making should take into account the platelet count and the causes of thrombocytopenia.In addition,the presence of bleeding tendency and platelet effects on other systemic disorders should be considered.Clinicians often need to make rapid decisions about whether to transfuse platelets in a critically situation.On the basis of the comprehensive overview of issues that are closely pertinent to the field of clinical practice,this article is dedicated to elucidate the advancements in clinical research pertaining to neonatal platelet transfusions,aiming to serve as a reference for clinicians when making transfusion decisions and to chart a course for future clinical investigations.